Thomas P. Grace, Andrew Edgington, Laura Reinhart, Timothy Burkart, Elisa Dyer, Jessica Halsey, Karim Baroudi, Christian Hicks, Jennifer E. Layne, Tomas C. Walker
The Dexcom Community Glucose Monitoring Project is a collaborative, ongoing, primary care–driven public health initiative designed to provide continuous glucose monitoring (CGM) systems to adults with type 2 diabetes who lack health insurance coverage for CGM. After 6 months of program participation, mean A1C decreased by 2.4 ± 1.9% from baseline to 6-month follow-up (from 9.4 ± 1.7 to 7.1 ± 1.2%, P <0.001). There was a clinically meaningful and statistically significant improvement in CGM metrics as well. Greater CGM use in the primary care setting among people with type 2 diabetes may help patients successfully manage their diabetes.
{"title":"The Dexcom Community Glucose Monitoring Project: Six-Month Results Using Continuous Glucose Monitoring in Type 2 Diabetes","authors":"Thomas P. Grace, Andrew Edgington, Laura Reinhart, Timothy Burkart, Elisa Dyer, Jessica Halsey, Karim Baroudi, Christian Hicks, Jennifer E. Layne, Tomas C. Walker","doi":"10.2337/cd24-0030","DOIUrl":"https://doi.org/10.2337/cd24-0030","url":null,"abstract":"The Dexcom Community Glucose Monitoring Project is a collaborative, ongoing, primary care–driven public health initiative designed to provide continuous glucose monitoring (CGM) systems to adults with type 2 diabetes who lack health insurance coverage for CGM. After 6 months of program participation, mean A1C decreased by 2.4 ± 1.9% from baseline to 6-month follow-up (from 9.4 ± 1.7 to 7.1 ± 1.2%, P <0.001). There was a clinically meaningful and statistically significant improvement in CGM metrics as well. Greater CGM use in the primary care setting among people with type 2 diabetes may help patients successfully manage their diabetes.","PeriodicalId":504780,"journal":{"name":"Clinical Diabetes","volume":"47 11","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141924443","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A table on the perioperative care of people with diabetes in the abridged version of section 16 of the American Diabetes Association’s Standards of Care in Diabetes—2024 contained typographical errors. The corrected version is as follows. The online version of this article (https://doi.org/10.2337/cd24-a016) has been updated to reflect this change. Perioperative Care A1C and glucose goals Elective surgery A1C goal: <8% (63.9 mmol/L) Blood glucose goal within 4 hours of surgery: 100–180 mg/dL (5.6–10.0 mmol/L) Medication adjustments Hold metformin on the day of surgery. Discontinue sodium–glucose cotransporter 2 inhibitors 3–4 days before surgery. Hold other oral glucose-lowering agents the morning of the surgery or procedure. There are few data on the safe use and/or influence of glucagon-like peptide 1 receptor agonists on glycemia and delayed gastric emptying in the perioperative period. Individualize plan based on clinical scenario and procedure/surgery. Insulin therapy adjustments Give half of NPH dose or 75–80% of long-acting analog insulin or adjust insulin pump basal rates based on diabetes type and clinical judgment.
{"title":"Erratum: 16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2024 Abridged for Primary Care Professionals. Clin Diabetes 2024;42:222 (doi: 10.2337/cd24-a016)","authors":"","doi":"10.2337/cd24-er03","DOIUrl":"https://doi.org/10.2337/cd24-er03","url":null,"abstract":"A table on the perioperative care of people with diabetes in the abridged version of section 16 of the American Diabetes Association’s Standards of Care in Diabetes—2024 contained typographical errors. The corrected version is as follows.\u0000 The online version of this article (https://doi.org/10.2337/cd24-a016) has been updated to reflect this change.\u0000 Perioperative Care A1C and glucose goals Elective surgery A1C goal: <8% (63.9 mmol/L) Blood glucose goal within 4 hours of surgery: 100–180 mg/dL (5.6–10.0 mmol/L) Medication adjustments Hold metformin on the day of surgery. Discontinue sodium–glucose cotransporter 2 inhibitors 3–4 days before surgery. Hold other oral glucose-lowering agents the morning of the surgery or procedure. There are few data on the safe use and/or influence of glucagon-like peptide 1 receptor agonists on glycemia and delayed gastric emptying in the perioperative period. Individualize plan based on clinical scenario and procedure/surgery. Insulin therapy adjustments Give half of NPH dose or 75–80% of long-acting analog insulin or adjust insulin pump basal rates based on diabetes type and clinical judgment.","PeriodicalId":504780,"journal":{"name":"Clinical Diabetes","volume":"24 11","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141117131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Laura C. Arena, Rachael Austin, N. Esquivel, Tara Vigil, Janice Kaelin-Kee, Susan Millstein
This study sought to understand the barriers to and facilitators of DSMES referrals and participation from multiple perspectives in New York. Two common barriers emerged: lack of awareness of DSMES services and limited access to DSMES services. Strategies that could improve DSMES referrals and participation include provider education, outreach to eligible patients, and tailoring of DSMES services to meet participants’ cultural needs and preferences. Future research is needed to assess the effectiveness of multicomponent strategies to increase DSMES participation in diverse populations.
{"title":"Understanding Barriers and Facilitators to Participating in Diabetes Self-Management Education and Support Services From Multiple Perspectives: Results of a Mixed-Methods Study of Medicaid Members, Medicaid Managed Care Organizations, and Providers in New York State","authors":"Laura C. Arena, Rachael Austin, N. Esquivel, Tara Vigil, Janice Kaelin-Kee, Susan Millstein","doi":"10.2337/cd23-0082","DOIUrl":"https://doi.org/10.2337/cd23-0082","url":null,"abstract":"This study sought to understand the barriers to and facilitators of DSMES referrals and participation from multiple perspectives in New York. Two common barriers emerged: lack of awareness of DSMES services and limited access to DSMES services. Strategies that could improve DSMES referrals and participation include provider education, outreach to eligible patients, and tailoring of DSMES services to meet participants’ cultural needs and preferences. Future research is needed to assess the effectiveness of multicomponent strategies to increase DSMES participation in diverse populations.","PeriodicalId":504780,"journal":{"name":"Clinical Diabetes","volume":"4 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141019554","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Increasing Diabetic Foot Exam Rates in Primary Care Via a Toolkit for Registered Nurses","authors":"Valerie S. Leonard","doi":"10.2337/cd23-0103","DOIUrl":"https://doi.org/10.2337/cd23-0103","url":null,"abstract":"","PeriodicalId":504780,"journal":{"name":"Clinical Diabetes","volume":" 8","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139790870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Increasing Diabetic Foot Exam Rates in Primary Care Via a Toolkit for Registered Nurses","authors":"Valerie S. Leonard","doi":"10.2337/cd23-0103","DOIUrl":"https://doi.org/10.2337/cd23-0103","url":null,"abstract":"","PeriodicalId":504780,"journal":{"name":"Clinical Diabetes","volume":"99 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139850644","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Elizabeth H. Golembiewski, Andrea E. Garcia Bautista, Eric C Polley, Guillermo E Umpierrez, Rodolfo J. Galindo, Juan P. Brito, Victor M. Montori, Janet P. Gockerman, Michael Tesulov, Bertina Labatte, Mindy M. Mickelson, Rozalina G. McCoy
This mixed-methods study sought to identify pharmacotherapy preferences among 40 noninsulin-treated adults with type 2 diabetes receiving care at two U.S. health care systems. Participants ranked by relative importance various health outcomes and medication attributes and then contextualized their rankings. Most participants ranked blindness (63%), death (60%), heart attack (48%), and heart failure (48%) as the most important health outcomes and glucose-lowering efficacy (68%) as the most important medication attribute, followed by oral administration (45%) and lack of gastrointestinal side effects (38%).
{"title":"Outomes and Attributes Patients Value When Choosing Glucose-Lowering Medications: A Mixed-Methods Study","authors":"Elizabeth H. Golembiewski, Andrea E. Garcia Bautista, Eric C Polley, Guillermo E Umpierrez, Rodolfo J. Galindo, Juan P. Brito, Victor M. Montori, Janet P. Gockerman, Michael Tesulov, Bertina Labatte, Mindy M. Mickelson, Rozalina G. McCoy","doi":"10.2337/cd23-0042","DOIUrl":"https://doi.org/10.2337/cd23-0042","url":null,"abstract":"This mixed-methods study sought to identify pharmacotherapy preferences among 40 noninsulin-treated adults with type 2 diabetes receiving care at two U.S. health care systems. Participants ranked by relative importance various health outcomes and medication attributes and then contextualized their rankings. Most participants ranked blindness (63%), death (60%), heart attack (48%), and heart failure (48%) as the most important health outcomes and glucose-lowering efficacy (68%) as the most important medication attribute, followed by oral administration (45%) and lack of gastrointestinal side effects (38%).","PeriodicalId":504780,"journal":{"name":"Clinical Diabetes","volume":"5 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139609417","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：